Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells.

MLA

Piven, Yuri A., et al. “Novel O-Acylated (E)-3-Aryl-6,7-Dihydrobenzisoxazol-4(5H)-One Oximes Targeting HSP90-HER2 Axis in Breast Cancer Cells.” Bioorganic & Medicinal Chemistry, vol. 53, Jan. 2022, p. 116521. EBSCOhost, https://doi.org/10.1016/j.bmc.2021.116521.

APA

Piven, Y. A., Yastrebova, M. A., Khamidullina, A. I., Scherbakov, A. M., Tatarskiy, V. V., Rusanova, J. A., Baranovsky, A. V., Zinovich, V. G., Khlebnicova, T. S., & Lakhvich, F. A. (2022). Novel O-acylated (E)-3-aryl-6,7-dihydrobenzisoxazol-4(5H)-one oximes targeting HSP90-HER2 axis in breast cancer cells. Bioorganic & Medicinal Chemistry, 53, 116521. https://doi.org/10.1016/j.bmc.2021.116521

Chicago

Piven, Yuri A, Margarita A Yastrebova, Alvina I Khamidullina, Alexander M Scherbakov, Victor V Tatarskiy, Julia A Rusanova, Alexander V Baranovsky, Veronica G Zinovich, Tatyana S Khlebnicova, and Fedor A Lakhvich. 2022. “Novel O-Acylated (E)-3-Aryl-6,7-Dihydrobenzisoxazol-4(5H)-One Oximes Targeting HSP90-HER2 Axis in Breast Cancer Cells.” Bioorganic & Medicinal Chemistry 53 (January): 116521. doi:10.1016/j.bmc.2021.116521.